Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.

ABSTRACT:

SUBMITTER: Seymour JF 

PROVIDER: S-EPMC5316338 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature